EUCROF encourages the initiatives of its Members to form Working Groups (WGs), which represent an open area of discussion on specific areas of interest for Members. Any (Associate) Member can contribute to the WGs by nominating a representative. The WGs meet regularly through TCs and/or face to face meetings. In accordance to the focus of each WG, they are intended to become counterpart/stakeholders for Regulatory Authorities, Industry, Academia and Patients' Associations, write papers in Scientific Journals, actively participate to Congresses/Conferences, thus representing the position and the interests of EUCROF.
Antoinette VAN DIJK
Switzerland
Phone: +41 79 51 17 359
Mobile: +39 335 56083680
E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.
WG Chair: Antoinette van Dijk
WG Members – Vivienne van de Walle (PT&R - The Netherlands), Ornela Cullufe (CVBF - Albania), Claudine Richon (Popsicube-fovea - France), Şebnem Yaşaroğulları (MENE Research - Turkey), Mahak Aneja (Emovis - Germany), Olga Baula (ULC - Ukraine).
Dagmar CHASE
BVMA
Phone: +49 89 92 92 87 0
Fax: +49 89 92 92 87 50
E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.
The EUCROF Clinical Trials Legislation Working Group (CTL WG) is aimed to represent European CROs when input is sought from stakeholders by legislators (e.g., EMA, EU Commission) or international organisations (e.g., ICH, WHO) in the context of new provisions for clinical trials. It is crucial that CROs provide their perspectives and opinions as more than 60% of clinical trials are handled by CROs. The delegation of sponsor duties and functions to CROs is important to be taken into account when legal regulations and guidance documents are developed. EUCROF does not miss this chance and continuously participates in the consultation rounds offered by legislators and/or international organisations.
The CTL WG is in operation since more than a decade and has given input to numerous documents with latest activities on the “Management of Clinical Trials under COVID-19 Pandemic”.
It is our mission to effectively use the voice we have through the European CRO Federation.
We are looking forward to continue our active involvement in the development of Clinical Trials documents.
WG Chair: Dagmar Chase
WG Members – Ulrike Lorch (Richmond Pharmacology - UK), Emma Akuffo (Richmond Pharmacology - UK), Maria Moumouri (Next CRO - Greece), Catherine Ferre (PRA Health Sciences - France), Catalina Sarbu (Parexel - Romania), Mihaela David (PSI CRO - Romania), Cristina Manfredi (CVBF - Italy), Vladimir Vujović (Optimapharm - Serbia), Ivan Vyshnyvetskyy (ULC - Ukraine), Cari Joacobs-Blom (CR2O - The Netherlands), Tineke de Boer (Pra Health Science - The Netherlands), Angela Hougardy (proDERM - Germany).
Christophe GOLENVAUX
BeCRO
E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.
WG Chair – Christophe Golenvaux
WG Members – Darina Hrdličková (ACRO-CZ - Czech Republic), Simon Lee (CCRA - UK), Véronique Marty (AFCROs - France), Mariangela Lupo (CVBF - Italy), Michael Shumilin (ULC - Ukraine), Assia Rosati (EUCROF).
Harry Therianos
Medical Director - Coronis Research S.A. (Athens, Greece)
Tel.: (+30)210.87.78.000
email: This email address is being protected from spambots. You need JavaScript enabled to view it.
WG Chair – Harry Therianos
WG Members – Maria Kyrana (Coronis Research - Greece), Phil Evans (CCRA/Quotient Sciences - UK), Nand Sing (CCRA/Quotient Sciences - UK), Yves Donazzolo (Eurofins Optimed - France), Maria Bernardo (PPD - Spain), Caridad Fernandez (PPD – Spain), Nadia Zeini (Premier Research - Spain), Emma Akuffo (Richmond Pharmacology - UK), Ralph Freese (CTC North, Germany), Annik van Riel (SGS - Belgium).
Donato BONIFAZI
Chief Executive Officer - Consorzio per Valutazioni Biologiche e Farmacologiche (CVBF, Italy)
Tel.: +39 080 975 1974
E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.
WG Chair – Donato Bonifazi
Harsha Basudev (Parexel - Italy), Simone Bucerius (FGK Clinical Research - Germany), Cristina Florescu (Avantyo Institute of Clinical Research - Romania), Manika Kreka (CVBF – Albania), Marta Lettieri (CVBF - Italy), Mariangela Lupo (CVBF - Italy), Marieke Meulemans (GCP Central - The Netherlands), Ana Stoiković (Optimapharm D.O.O. - Croatia), Katerina Tsagaraki (Coronis Research - Greece), Goran Vesov (Optimapharm D.O.O. - Croatia).
Dolores Pérez Méndez
Sermes CRO, Spain
Phone: +34 608 505 507
Mail: This email address is being protected from spambots. You need JavaScript enabled to view it.
WG Chair – Dolores Pérez Méndez
WG Members – Stefan Siegmund (Convidia - Germany), Rasid Kamal (PPD - Czech Republic), Lari Forrester (IQVIA - The Netherlands).
The goal of this WG is to identify, examine and provide solutions to the principal issues identified in Advanced Therapy Medical Products development and regulation, in constant dialogue and collaboration with the Industry and European Authorities.
Meeting by teleconference (Monthly/ every two months)
Alexandre Malouvier
Senior Director Commercial & Strategic Healthcare & Technology Partnerships
Dir Tel: +33 (0)1 41 34 45 59
Mobile: + 33 (0)6 14 34 72 31
email: This email address is being protected from spambots. You need JavaScript enabled to view it.
WG Chair: Alexandre Malouvier
WG Co-chair: Denis Comet (Axonal - France)
WG Members: Sarah Beeby (consultant - UK), Liliana Cunha (Clinical Trial & Consulting - Portugal), Remi Gauchon (ICTA - France), Sebastiaan Knijnenburg (Castor EDC - The Netherlands), Sonja Kroep (Pharmerit - The Netherlands), Sofoklis Kyriazakos (Innovation Sprint - Belgium), Klairi Liakou (Zeincro - Greece), Georgie Nock (pH Associates – UK), Nawab Qizilbash (OXON Epidemiology - UK), Giuseppe Recchia (daVinci Digital Therapeutics - Italy), Berber Snoeijer (ClinLine - The Netherlands), Dana Vankova (IQVIA - Czech Republic), Ophélie Wilczynski (Carenity - France).
Monthly meeting is generally organized through teleconference
Vice President Clinical Operations
email: This email address is being protected from spambots. You need JavaScript enabled to view it.
MENE Health Group
Phone. +90(262) 678 88 67 - Fax. +90(262) 751 28 38 - Cell. +90(533) 740 84 63
www.menehealthgroup.com
Members
WG Chair – Şebnem Yaşaroğulları
WG Members – Antoinette van Dijk (D.O. Research - Switzerland), Vitaliy Demyanenko (ULC - Ukraine), Richard Fontannelles (Anagram - Spain), Karen Gabriels (Archer Research - Belgium), Sofoklis Kyriazakos (Innovation Sprint - Belgium), Christelle Mekaoui (Clinica Group - Algeria), Antonio Pitarque(Sermes CRO - Spain), Rob Schneijdenberg (Syneos Health - The Netherlands), Mieke Tempels (Archer Research - Belgium), Rianne Tooten (Acron - The Netherlands) .
Alan Yeomans
Quality Manager
PCG Solutions AB
Mobile : +46 70 540 0299
This email address is being protected from spambots. You need JavaScript enabled to view it.
Co-Chair
Yoani Matsakis
President
TELEMEDICINE TECHNOLOGIES S.A.S.
Mobile: +33 6 85 04 57 21
This email address is being protected from spambots. You need JavaScript enabled to view it.
The group evaluates new technologies that impact the clinical trial environment and evaluates how these can benefit clinical research.
WG Chair – Alan Yeomans
WG Co-chair – Yoani Matsakis
WG Initiator – Yoani Matsakis
WG Members – Thierry Lepoutre (Lambdaplus – Belgium), Vasiliki Mani (Excelya - Greece), Sofoklis Kyriazakos (Alcoam By Design - France), Sarah Dubray (ICON - France), Ignacio Jimenz (Sermes – Spain), Keith Berelowitz (Richmond Pharmacology – UK), Fiona Maini (Medidata Solutions - UK), [Mika Lindroos, Finland - eCF; Dagmar Chase, Germany - REG].
Meetings
Webinar meetings are approximately once a month (about 10 times a year).
Face-to-face meetings can be held in conjunction with EUCROF conferences if there is a need.
Dr Martine DEHLINGER-KREMER
PRA Health Sciences (Germany)
Phone: +49 1738966437
E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.
WG Chair – Dr Martine Dehlinger-Kremer
WG Members – Alex Cvetkovic Muntañola (Syneos Health – Spain), Sofia Romboli (Excelya - Greece), Jürgen Schäfer (Conreso GmbH – Germany), Donato Bonifazi (CVBF – Italy), Nira Garty (Perfection-CRO Ltd – Israel), Erik Hamminga (Covance - The Netherlands), Pavla Nevolova (EastHORN - Czech Republic), Ian Vasicka (Co-Investigator/Advisor - Czech Republic), Nuria Martinez-Alier (IQVIA/Advisor – UK).
Marta Manso
This email address is being protected from spambots. You need JavaScript enabled to view it.
Business Development
SERMES CRO
Fostering actual & confident collaboration with patients in clinical research.
WG Members – Marta Manso (Spain), Mariangela Lupo (Italy), Simon Klaasen (The Netherlands), Manika Face Kreka (Albania), Ornela Cullufe (Albania), Hélène Moussu (France), Miriam Cabrita (Belgium), Annick Daems (Belgium), Joan Escudero (Spain), Helen Green (UK), Fanny Rossignon (The Netherlands), David Blanco (Spain), Karen McIntyre (UK), Karen Bailey (UK), Sue Fitzpatrick (UK).
Webinar meetings on a monthly base.
Face-to-face meetings.
Nicolas TSIAKKAS
Scientific Director
Medwork Pharma Research & Consulting
5, Chiou st., 164 52 Argyroupoli, Athens, Greece
Phone: +30 210 9960971
Fax: +30 210 9969578
Xavier FOURNIE
Corporate Medical Director
Vice-President, Global Medical Affairs - ICON Commercialisation & Outcomes
Phone: +33 (0)4 72 13 66 85
Mobile: +33 (0)6 88 20 00 61
27 rue de la Villette | 69003 LYON | FRANCE
This email address is being protected from spambots. You need JavaScript enabled to view it.
Position EUCROF PV WG as important conduit and as a reference for stakeholders in the EU pharmacovigilance fora
Main objectives:
WG Chair – Nicolas Tsiakkas
WG Co-chair – Xavier Fournie
WG Members – Marco Anelli (Productlife-group – Italy), Zurab Koberidze (FGK-PV – Germany), Fleming Kjær Jørgensen (Klifo – Denmark).
EUCROF Medical Device WG Brochure
EUCROF Paediatric WG Brochure